Lastly, the present study has not included any survival analysis, which potentially limits the evaluation of the prognostic ability of CHIT1 and YKL-40 in IPF patients treated with antifibrotics. The gene discussed is CHIT1; the disease is idiopathic pulmonary fibrosis.